Predicting drug metabolism-dependent toxicity

被引：0
|
作者：
Hermann M. Bolt
Jan G. Hengstler
机构：
[1] Leibniz Research Centre for Working Environment and Human Factors (IfADo),
[2] TU Dortmund,undefined
来源：
Archives of Toxicology | 2009年 / 83卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：635 / 638
页数：3
相关论文
共 50 条
  • [31] UREA METABOLISM-DEPENDENT BASE FORMATION IN PLAQUE AND SALIVARY SEDIMENT
    SISSONS, CH
    PEARCE, EIF
    JOURNAL OF DENTAL RESEARCH, 1985, 64 (04) : 653 - 653
  • [32] Safety evaluation of dermal exposure to phthalates: Metabolism-dependent percutaneous absorption
    Sugino, Masahiro
    Hatanaka, Tomomi
    Todo, Hiroaki
    Mashimo, Yuko
    Suzuki, Takamasa
    Kobayashi, Miho
    Hosoya, Osamu
    Jinno, Hideto
    Juni, Kazuhiko
    Sugibayashi, Kenji
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2017, 328 : 10 - 17
  • [33] Capturing Metabolism-Dependent Solvent Polarity Fluctuations in a Trafficking Lysosome
    Begarani, Filippo
    D'Autilia, Francesca
    Signore, Giovanni
    Gratton, Enrico
    Beltram, Fabio
    Cardarelli, Francesco
    BIOPHYSICAL JOURNAL, 2019, 116 (03) : 307A - 307A
  • [34] Rofecoxib is a potent, metabolism-dependent inhibitor of CYP1A2: Implications for in vitro prediction of drug interactions
    Karjalainen, Marjo J.
    Neuvonen, Pertti J.
    Backman, Janne T.
    DRUG METABOLISM AND DISPOSITION, 2006, 34 (12) : 2091 - 2096
  • [35] Drug metabolism and drug toxicity
    B. Kevin Park
    Neil R. Kitteringham
    Jane R. Kenny
    Munir Pirmohamed
    InflammoPharmacology, 2001, 9 (1-2) : 183 - 199
  • [36] Innovative molecule may target metabolism-dependent growth in breast cancer
    Brown, Emily
    WOMENS HEALTH, 2013, 9 (05) : 428 - 428
  • [37] Pyrrolzidine alkaloids - Metabolism-dependent molecular effects in human endothelial cells
    Ebmeyer, J.
    Lorenz, M.
    Braeuning, A.
    Lampen, A.
    Hessel-Pras, S.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2018, 391 : S47 - S48
  • [38] A novel form of glycolytic metabolism-dependent cardioprotection revealed by PKCα and β inhibition
    Brennan, Sean
    Chen, Shen
    Makwana, Samir
    Martin, Christopher A.
    Sims, Mark W.
    Alonazi, Asma S. A.
    Willets, Jonathan M.
    Squire, Iain B.
    Rainbow, Richard D.
    JOURNAL OF PHYSIOLOGY-LONDON, 2019, 597 (17): : 4481 - 4501
  • [39] ROLE OF ALDEHYDE DEHYDROGENASE IN THE METABOLISM-DEPENDENT BIOLOGICAL-ACTIVITY OF CYCLOPHOSPHAMIDE
    HIPKENS, JH
    STRUCK, RF
    GURTOO, HL
    CANCER RESEARCH, 1981, 41 (09) : 3571 - 3583
  • [40] Glucuronidation converts gemfibrozil to a potent, metabolism-dependent inhibitor of CYP2C8: Implications for drug-drug interactions
    Ogilvie, BW
    Zhang, DL
    Li, WY
    Rodrigues, AD
    Gipson, AE
    Holsapple, J
    Toren, P
    Parkinson, A
    DRUG METABOLISM AND DISPOSITION, 2006, 34 (01) : 191 - 197
12345